RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

ALPS ADVISORS INC's Holding History (CIK: 0001376113)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023

Shares 156,214 Value ($000) $1,195 Avg Close $9.98 Range $6.44 - $16.75

Q2 2023

Shares 141,396 Value ($000) $1,056 Avg Close $7.00 Range $4.54 - $10.45

Q1 2023

Shares 126,011 Value ($000) $840 Avg Close $7.93 Range $6.40 - $9.73

Q4 2022

Shares 123,165 Value ($000) $950 Avg Close $9.81 Range $7.04 - $13.29

Q3 2022

Shares 90,188 Value ($000) $960 Avg Close $10.13 Range $7.48 - $14.18

Q2 2022

Shares 102,290 Value ($000) $833 Avg Close $6.69 Range $4.92 - $9.40

Q1 2022

Shares 173,678 Value ($000) $1,244 Avg Close $10.63 Range $5.80 - $18.23

Q4 2021

Shares 184,614 Value ($000) $3,162 Avg Close $18.82 Range $15.25 - $23.86

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2023	156,214	$1,195	$9.98	$6.44 - $16.75
Q2 2023	141,396	$1,056	$7.00	$4.54 - $10.45
Q1 2023	126,011	$840	$7.93	$6.40 - $9.73
Q4 2022	123,165	$950	$9.81	$7.04 - $13.29
Q3 2022	90,188	$960	$10.13	$7.48 - $14.18
Q2 2022	102,290	$833	$6.69	$4.92 - $9.40
Q1 2022	173,678	$1,244	$10.63	$5.80 - $18.23
Q4 2021	184,614	$3,162	$18.82	$15.25 - $23.86